Np mrd loader

Record Information
Version2.0
Created at2022-04-28 23:27:41 UTC
Updated at2022-04-28 23:27:41 UTC
NP-MRD IDNP0078365
Secondary Accession NumbersNone
Natural Product Identification
Common NameBufalin
DescriptionBufalin belongs to the class of organic compounds known as bufanolides and derivatives. These are steroid lactones containing a pyran-2-one moiety linked to the C17 atom of a cyclopenta[a]phenanthrene derivative. Thus, bufalin is considered to be a sterol. Bufalin is found in Apis cerana, Bufo bankorensis, Bufo bufo, Bufo gargarizans, Cunninghamella blakesleana, Cunninghamella blakesleeana, Duttaphrynus melanostictus, Bryophyllum pinnatum and Phrynoidis asper. Bufalin was first documented in 2022 (PMID: 35409366). Based on a literature review a small amount of articles have been published on bufalin (PMID: 35345394) (PMID: 35241510) (PMID: 35235052) (PMID: 35153791).
Structure
Thumb
Synonyms
ValueSource
3,14-Dihydroxy-bufa-20,22-dienolideChEBI
3-beta,14-Dihydroxy-5-beta-bufa-20,22-dienolideChEBI
3beta,14beta-Dihydroxy-5beta-bufa-20,22-dienolideChEBI
(3beta,5beta)-3,14-Dihydroxybufa-20,22-dienolideKegg
3-b,14-Dihydroxy-5-b-bufa-20,22-dienolideGenerator
3-Β,14-dihydroxy-5-β-bufa-20,22-dienolideGenerator
3b,14b-Dihydroxy-5b-bufa-20,22-dienolideGenerator
3Β,14β-dihydroxy-5β-bufa-20,22-dienolideGenerator
(3b,5b)-3,14-Dihydroxybufa-20,22-dienolideGenerator
(3Β,5β)-3,14-dihydroxybufa-20,22-dienolideGenerator
Bufalin, (3alpha,5beta)-isomerMeSH
Chemical FormulaC24H34O4
Average Mass386.5320 Da
Monoisotopic Mass386.24571 Da
IUPAC Name5-[(1S,2S,5S,7R,10R,11S,14S,15R)-5,11-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2H-pyran-2-one
Traditional Name5-[(1S,2S,5S,7R,10R,11S,14S,15R)-5,11-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pyran-2-one
CAS Registry NumberNot Available
SMILES
C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=COC(=O)C=C1
InChI Identifier
InChI=1S/C24H34O4/c1-22-10-7-17(25)13-16(22)4-5-20-19(22)8-11-23(2)18(9-12-24(20,23)27)15-3-6-21(26)28-14-15/h3,6,14,16-20,25,27H,4-5,7-13H2,1-2H3/t16-,17+,18-,19+,20-,22+,23-,24+/m1/s1
InChI KeyQEEBRPGZBVVINN-BMPKRDENSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Apis ceranaLOTUS Database
Bufo bankorensisLOTUS Database
Bufo bufoLOTUS Database
Bufo gargarizansLOTUS Database
Cunninghamella blakesleanaFungi
Cunninghamella blakesleeanaLOTUS Database
Duttaphrynus melanostictusLOTUS Database
Kalanchoe pinnataPlant
Phrynoidis asperLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as bufanolides and derivatives. These are steroid lactones containing a pyran-2-one moiety linked to the C17 atom of a cyclopenta[a]phenanthrene derivative.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassSteroid lactones
Direct ParentBufanolides and derivatives
Alternative Parents
Substituents
  • Bufanolide-skeleton
  • 3-hydroxysteroid
  • 14-hydroxysteroid
  • Hydroxysteroid
  • 3-beta-hydroxysteroid
  • Pyranone
  • Pyran
  • Tertiary alcohol
  • Heteroaromatic compound
  • Cyclic alcohol
  • Secondary alcohol
  • Lactone
  • Oxacycle
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.25ALOGPS
logP3.28ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)18.3ChemAxon
pKa (Strongest Basic)0.28ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area66.76 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity108.49 m³·mol⁻¹ChemAxon
Polarizability43.26 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00042323
Chemspider ID7826155
KEGG Compound IDC16922
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkBufalin
METLIN IDNot Available
PubChem Compound9547215
PDB IDNot Available
ChEBI ID517248
Good Scents IDNot Available
References
General References
  1. Sampath V, Horesh N, Sasi B, Zannadeh H, Pogodin I, Singh SV, Deutsch J, Lichtstein D: Synthesis and Biological Evaluation of Novel Bufalin Derivatives. Int J Mol Sci. 2022 Apr 4;23(7):4007. doi: 10.3390/ijms23074007. [PubMed:35409366 ]
  2. Jiang HY, Zheng HM, Xia C, Li X, Wang G, Zhao T, Cui XN, Wang RY, Liu Y: The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma. Onco Targets Ther. 2022 Mar 22;15:291-298. doi: 10.2147/OTT.S333233. eCollection 2022. [PubMed:35345394 ]
  3. Kuo JY, Liao CL, Ma YS, Kuo CL, Chen JC, Huang YP, Huang WW, Peng SF, Chung JG: Combination Treatment of Sorafenib and Bufalin Induces Apoptosis in NCI-H292 Human Lung Cancer Cells In Vitro. In Vivo. 2022 Mar-Apr;36(2):582-595. doi: 10.21873/invivo.12741. [PubMed:35241510 ]
  4. Kreutzer FP, Meinecke A, Mitzka S, Hunkler HJ, Hobuss L, Abbas N, Geffers R, Weusthoff J, Xiao K, Jonigk DD, Fiedler J, Thum T: Development and characterization of anti-fibrotic natural compound similars with improved effectivity. Basic Res Cardiol. 2022 Mar 2;117(1):9. doi: 10.1007/s00395-022-00919-6. [PubMed:35235052 ]
  5. Yu CC, Li Y, Cheng ZJ, Wang X, Mao W, Zhang YW: Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions. Front Pharmacol. 2022 Jan 27;13:818179. doi: 10.3389/fphar.2022.818179. eCollection 2022. [PubMed:35153791 ]